1989
DOI: 10.1097/00005344-198904000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0

Year Published

1990
1990
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 0 publications
1
12
0
Order By: Relevance
“…However, the large difference in the EC50 value for positive inotropy and the IC50 concentration for PDE 111 inhibition with amrinone indicates that there is no direct correlation between these two parameters. Similar disparities between EC50 and IC50 values have been reported for other PDE 111 selective inhibitors (Brunkhorst et a1 1989;Silver et al 1989;Shahid & Nicholson 1991). The exact reasons for this discrepancy are not clear but it is possible that increases in cAMP produced by PDE 111 inhibition alone may be limited by the relative activities and distribution of PDE I, PDE I1 and PDE IV.…”
Section: Discussionsupporting
confidence: 52%
“…However, the large difference in the EC50 value for positive inotropy and the IC50 concentration for PDE 111 inhibition with amrinone indicates that there is no direct correlation between these two parameters. Similar disparities between EC50 and IC50 values have been reported for other PDE 111 selective inhibitors (Brunkhorst et a1 1989;Silver et al 1989;Shahid & Nicholson 1991). The exact reasons for this discrepancy are not clear but it is possible that increases in cAMP produced by PDE 111 inhibition alone may be limited by the relative activities and distribution of PDE I, PDE I1 and PDE IV.…”
Section: Discussionsupporting
confidence: 52%
“…Milrinone is a selective PDE3 inhibitor with pharmacological effects, including relaxation of vascular smooth muscle, enhanced myocardial contractility (inotropy) and improved myocardial relaxation (lusitropy). 19,20 In the newborn lamb model, intravenous milrinone augments the action of PGl 2 (prostaglandins) on pulmonary vasculature by significantly shortening the onset and prolonging the duration and degree of pulmonary vasodilation produced by PGI 2 . 21,22 Milrinone may also exhibit synergistic effects with iNO in lowering PVR.…”
Section: Discussionmentioning
confidence: 99%
“…PDE inhibitors affect myocardial function in multiple ways: (1) increased inotropy as a result of cyclic adenosine monophosphatemediated increase in trans-sarcolemmal calcium influx [21], (2) peripheral vasodilatation secondary to removal of free intracellular calcium by causing its uptake by sarcoplasmic reticulum [4], and (3) myocyte relaxation (lusitropy) possibly due to improved actin-myosin complex dissociation [23]. These non-glycoside non-catecholamine agents improve myocardial performance without raising myocardial oxygen consumption [11].…”
Section: Milrinone As Inodilatormentioning
confidence: 99%